قالب وردپرس درنا توس
Home / US / House democrats ready to disrupt GOP over the vote on drug pricing

House democrats ready to disrupt GOP over the vote on drug pricing







  Greg Walden "/ =" Greg Walden "/> </source></source></source></source></picture>
            </div><figcaption>
<p>
                " It did not have to be that way, "Republican Rep. Greg Walden said. | Zach Gibson / Getty Images </p>
</figcaption></figure>
</p></div>
<p>  House democrats are taking their first big step on Thursday but not before they make life difficult for the Republicans who have helped them. <b> </b>  The Parliament <b><i> </i></b>  will vote on three cross-party drug prices, which the Democratic leaders will face with a series of Suggestions to reverse the efforts of the Trump government to undermine Obamacare, which is likely to force most Republicans to sink the package and be seen as opposing efforts to control drug costs Kill chances of legislation in the GOP-controlled Senate. </p>
<p class= Below

The tactic has Republicans r angry, who spent months bargaining for lawsuits against pharmaceutical companies, and even made them rant of moderate Democrats are anxious to demonstrate some degree of bipartisanism regarding the highest priority in health care.

"I'm not very happy at all," said Rep. Buddy Carter (R-Ga.), Whose bill limited the ability of generic drug manufacturers to block competitors. "They know we can not support this, and I think it's bad politics when they do that."

The House democrats defend the maneuver as a budgetary necessity. The trio of drug prices would together save about $ 4 billion in a decade and turn them into valuable compensation payments for the Obamacare bills, which would require higher federal spending to support health insurance insurance markets and reverse the government-imposed cuts ,

It is expected that none of the drug pricing policies will drastically reduce drug costs. However, they would limit the anticompetitive behavior of pharmaceutical companies and address a topic that, according to polls, is well received by voters from all political circles.

Republicans of the Energy and Commerce Committee, which unanimously voted to bring the bills to the ground last month, unsuccessfully tried to persuade Democratic leaders to hold separate votes on Tuesday evening's measures of action on a house-building session Drug pricing – and they accused them of sacrificing good legislation in order to gain political points.

"It did not have to be that way," said MP Greg Walden (R-Ore.), The senior member of the committee. "But they are just waiting to turn off the TV commercial."

The harsh feelings could penetrate other general health policy priorities such as protecting patients from "surprising" medical bills and a number of important health policy enhancements. 19659005] "For Republicans, they say we did that once, but we have to trust you again," said Rodney Whitlock, a health consultant and former GOP congressional assistant. "This is the first time – if there is a second time." Until then there will be no third. "

The inclusion of the Obamacare provisions almost certainly ensures that the Senate ignores the combined package and leaves pricing policies in abeyance.

House-Democratic leaders tentatively plan A person familiar with the considerations said that they would need to revive these bills later this year and include them in more comprehensive legislation, which would prove risky and up to a half in the process Could delay the year.

is turning to a stronger one I have a position in the Senate if they do non-partisan work, "Whitlock said. "That effectively means that this will not be the case."

The Democratic leaders concluded that the political benefits of drawing up a single health package outweighed these risks, according to those familiar with the strategy, especially with regard to a party-centric issue on its pre-2020 platform.

The Democrats have already found a handful of Republicans ready to pay the health care of the Trump government. Four moderate republicans broke the law to reverse the Trump guidelines last week and encouraged states to evade important Obamacare patient protection measures.